Accessing health services for musculoskeletal diseases during early COVID-19 lockdown: results from a UK population survey. by Smith, Toby O. et al.
Letter to the Editor (Other)
Rheumatology Advances in Practice 2020;0:1–3
doi: 10.1093/rap/rkaa047
Advance Access Publication 22 September 2020
Accessing health services for musculoskeletal
diseases during early COVID-19 lockdown: results
from a UK population survey
SIR, restricting the spread of COVID-19 in the UK re-
quired radical changes to the structure of society and
the delivery of health care. This has the potential for
wide-ranging adverse consequences for people with
musculoskeletal diseases. For the period between 23
March and 1 August 2020, those determined to be most
at risk were required to ‘shield’ at home, avoiding all so-
cial contact. Primary and secondary care services post-
poned or cancelled non-urgent appointments. Remote
consultations were provided by telephone or video [1].
The public were encouraged only to use health-care
services for urgent needs. Local pharmacies, although
remaining open, reported reduced patient consultations.
Non-National Health Service (NHS) providers of muscu-
loskeletal health services, including physiotherapists and
podiatrists, closed [2].
In late April 2020, 5 weeks after the start of the UK
‘lockdown’, we conducted an online survey in a group
of patients with a range of musculoskeletal diseases to
assess the impact that the measures had on their well-
being and ability to access health care. The survey was
conducted using the Qualtrics platform (XM Platform,
Qualtrics LLC, USA). It targeted 1376 subjects enrolled
on the Norfolk Arthritis Register (NOAR), a large
population-based cohort of patients originally identified
as having inflammatory arthritis [3], and was also distrib-
uted to the wider UK population through social media
and email lists from organizations including Arthritis
Action, National RA Society, National Ankylosing
Spondylitis Society, Fibromyalgia UK and Scope. The
survey was open from 28 April 2020 to 27 May 2020.
Respondents provided informed consent and were
asked a series of questions relating to demographic
characteristics, use of health-care services, disease ac-
tivity, disability status, perceived isolation (measured us-
ing the Lubben Social Network Scale-6 [4]) and
loneliness (measured using the revised UCLA Loneliness
Score-3 item [5]). Descriptive statistics were used to
summarize the characteristics of the sample and their
access to health service provision. Student’s unpaired t-
tests were used to assess the association between par-
ticipants’ access to health care (yes/no) and continuous
measures of pain, stiffness, perceived general health,
Lubben Social Isolation (scored from 0 to 30; higher
scores equate to greater social isolation) and UCLA
loneliness score (scored from 3 to 9; higher scores
equate to greater loneliness). The statistical analyses
were conducted on STATA v.16.0 (StataCorp, College
Station, TX, USA). The study was approved by the
University of East Anglia’s Faculty of Medicine and
Health Sciences Research Ethics Committee (reference:
2019/20-104; 2019/20-105).
In total, 264 responded from the NOAR cohort (19%),
and 414 from the wider population completed the sur-
vey. This provided a combined cohort of 678 respond-
ents for analysis. Their characteristics and survey
responses are summarized in Table 1. A wide range of
inflammatory and non-inflammatory diseases were rep-
resented, with RA (43.5%) and OA (21.7%) reported
most commonly. There were no important differences in
the characteristics or responses in the NOAR and non-
NOAR RA patients, and the results were pooled for
analysis.
The majority (52.1%) reported that their musculoskele-
tal symptoms had increased since the start of ‘lock-
down’. Most respondents (88.2%) reported little
difficulty accessing medication. Forty-four per cent of
respondents needed the assistance of others to do this.
A third of patients reported needing to access either
their general practitioner or hospital rheumatology de-
partment in this period. The respondents gave equivocal
responses when asked about the challenges in obtaining
advice from health professionals. As might be expected,
those who accessed health care reported significantly
greater pain, stiffness and poorer general health
(P<0.01). Individuals who reported greater social isola-
tion (mean difference 1.0 points; P¼0.02) and greater
loneliness (mean difference 0.6 points; P< 0.01) were
less likely to access health care. Although these differ-
ences reflect relatively small differences in degrees of
social isolation, their statistical significance indicates the
wider impact on the health-seeking behaviours of
patients.
This survey, conducted in the early stages of the UK
‘lockdown’, suggests that there have been immediate
negative consequences for people with musculoskeletal
disease. Despite the swift transformations in the config-
uration of health care that have taken place, patients
have, in the main, been able to access primary care and
hospital rheumatology departments. However, those
with higher levels of social isolation access health care
the least.
Should further isolation measures need to be enforced
as the pandemic continues, particular efforts should be
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TABLE 1 Respondent characteristics and responses to health provision access from April to May 2020
Characteristics Frequency (%)
N 678
Gender Female 550 (81.1)
Male 125 (18.4)
Non-binary 1 (0.1)
Prefer to self-describe 1 (0.1)
Prefer not to say 1 (0.1)







Region of respondent England 640 (94.4)
Scotland 19 (2.8)
Wales 17 (2.5)
Northern Ireland 2 (0.3)
Ethnic group White 660 (97.3)
Mixed/multiple ethnic group 6 (0.9)
Asian 7 (1.0)
Black, African, Caribbean 2 (0.3)
Arab 1 (0.1)
Musculoskeletal diagnosis RA 295 (43.5)
OA 147 (21.7)
Mechanical low back pain 66 (9.7)
FM 64 (9.4)
PsA 62 (9.1)
Inflammatory polyarthritis 62 (9.1)
Hypermobility 40 (5.9)
Specific musculoskeletal diagnosis not
reported
32 (4.7)




Ligament/tendon injury/bursitis 9 (1.3)
Neck pain 6 (0.9)
Gout 5 (0.7)
Other 60 (8.6)
How have your musculoskeletal symp-
toms been since the COVID meas-
ures started?
Decreased 42 (6.3)
Stayed the same 279 (41.6)
Increased 349 (52.1)
Pain, scale: 0–10 Mean (S.D.) 4.8 (2.6)
Stiffness, scale: 0–10 Mean (S.D.) 4.9 (2.9)
General health, scale: 0–10 Mean (S.D.) 4.1 (2.4)
Total Lubben Social Network Score,
scale: 0–30
Mean (S.D.) 20.7 (5.7)
Total UCLA Loneliness, scale: 3–9 Mean (S.D.) 5.1 (2.0)
Difficulty accessing medication Yes 79 (11.8)
No 592 (88.2)












Who did you contact General practitioner 152 (22.5)
Practice nurse/GP nurse practitioner 22 (3.2)
Rheumatology department 88 (13.0)
Physiotherapy or occupational therapist 16 (2.4)
(continued)
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vulnerable group. In designing musculoskeletal services,
health-care providers need to use their resources to
reach out to individual patients who do not come for-
ward for advice and who might be struggling silently
with their disease.
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Private chiropractor, osteopath or
massage therapist
1 (0.1)
Royal Osteoporosis Society 1 (0.1)
Endocrinology department 7 (1.0)
Pain clinic 2 (0.3)
Counsellor or health psychologist 2 (0.3)
Massage therapist 1 (0.1)
Podiatrist 1 (0.1)
Nutritionist 1 (0.1)
NHS 111 2 (0.3)
How easy has it been to get advice?
Scale: 0–10
Mean (S.D.) 4.8 (3.3)
A&E: accident and emergency; GP, general practitioner; NHS: National Health Service; UCLA: University of California Los
Angeles.
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